ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global POCT Molecular Diagnostics Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-28K12683
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global POCT Molecular Diagnostics Market Research Report 2023
BUY CHAPTERS

Global POCT Molecular Diagnostics Market Research Report 2025

Code: QYRE-Auto-28K12683
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abbott Laboratories
Roche Holding AG
BioFire Diagnostics
DAAN Gene
Sansure Biotech
Genmark Diagnostics, Inc.
Mobidiag
Wondfo
Coyote Bioscience Co., Ltd.
Ustar Biotechnologies (Hangzhou) Ltd.
Cepheid Inc
Beijing Bohui Innovat Biotech Grp Co Ltd.
CapitalBio Corporation

POCT Molecular Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

POCT Molecular Diagnostics Market

POCT Molecular Diagnostics Market

The global market for POCT Molecular Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
POCT Molecular Diagnostics refers to the use of molecular testing techniques in Point-of-Care Testing (POCT) settings. Point-of-Care Testing involves performing medical diagnostic tests near the patient, often at the bedside or in a decentralized setting, rather than sending samples to a central laboratory for analysis. Molecular diagnostics, on the other hand, focuses on identifying and analyzing specific genetic material, such as DNA or RNA, to diagnose diseases, detect pathogens, and monitor treatment responses.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for POCT Molecular Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding POCT Molecular Diagnostics.
The POCT Molecular Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global POCT Molecular Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the POCT Molecular Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of POCT Molecular Diagnostics Market Report

Report Metric Details
Report Name POCT Molecular Diagnostics Market
CAGR 5%
Segment by Type
  • Molecular Point-of-Care Diagnostics
  • Near-Patient Molecular
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ustar Biotechnologies (Hangzhou) Ltd., Cepheid, Abbott Laboratories, Roche Holding AG, BioFire Diagnostics, Beijing Bohui Innovat Biotech Grp Co Ltd., CapitalBio Corporation, Daan Gene, Sansure Biotech, Coyote Bioscience Co., Ltd., Genmark Diagnostics, Inc., Mobidiag, Wondfo
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of POCT Molecular Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of POCT Molecular Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the POCT Molecular Diagnostics Market report?

Ans: The main players in the POCT Molecular Diagnostics Market are Ustar Biotechnologies (Hangzhou) Ltd., Cepheid, Abbott Laboratories, Roche Holding AG, BioFire Diagnostics, Beijing Bohui Innovat Biotech Grp Co Ltd., CapitalBio Corporation, Daan Gene, Sansure Biotech, Coyote Bioscience Co., Ltd., Genmark Diagnostics, Inc., Mobidiag, Wondfo

What are the Application segmentation covered in the POCT Molecular Diagnostics Market report?

Ans: The Applications covered in the POCT Molecular Diagnostics Market report are Microbiology Laboratory, Hospital, Clinic

What are the Type segmentation covered in the POCT Molecular Diagnostics Market report?

Ans: The Types covered in the POCT Molecular Diagnostics Market report are Molecular Point-of-Care Diagnostics, Near-Patient Molecular

Recommended Reports

Diagnostic Testing Markets

Molecular Diagnostics

Point-of-Care Devices

1 POCT Molecular Diagnostics Market Overview
1.1 Product Definition
1.2 POCT Molecular Diagnostics by Type
1.2.1 Global POCT Molecular Diagnostics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Molecular Point-of-Care Diagnostics
1.2.3 Near-Patient Molecular
1.3 POCT Molecular Diagnostics by Application
1.3.1 Global POCT Molecular Diagnostics Market Value by Application (2024 VS 2031)
1.3.2 Microbiology Laboratory
1.3.3 Hospital
1.3.4 Clinic
1.4 Global POCT Molecular Diagnostics Market Size Estimates and Forecasts
1.4.1 Global POCT Molecular Diagnostics Revenue 2020-2031
1.4.2 Global POCT Molecular Diagnostics Sales 2020-2031
1.4.3 Global POCT Molecular Diagnostics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 POCT Molecular Diagnostics Market Competition by Manufacturers
2.1 Global POCT Molecular Diagnostics Sales Market Share by Manufacturers (2020-2025)
2.2 Global POCT Molecular Diagnostics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global POCT Molecular Diagnostics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of POCT Molecular Diagnostics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of POCT Molecular Diagnostics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of POCT Molecular Diagnostics, Product Type & Application
2.7 Global Key Manufacturers of POCT Molecular Diagnostics, Date of Enter into This Industry
2.8 Global POCT Molecular Diagnostics Market Competitive Situation and Trends
2.8.1 Global POCT Molecular Diagnostics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest POCT Molecular Diagnostics Players Market Share by Revenue
2.8.3 Global POCT Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global POCT Molecular Diagnostics Market Scenario by Region
3.1 Global POCT Molecular Diagnostics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global POCT Molecular Diagnostics Sales by Region: 2020-2031
3.2.1 Global POCT Molecular Diagnostics Sales by Region: 2020-2025
3.2.2 Global POCT Molecular Diagnostics Sales by Region: 2026-2031
3.3 Global POCT Molecular Diagnostics Revenue by Region: 2020-2031
3.3.1 Global POCT Molecular Diagnostics Revenue by Region: 2020-2025
3.3.2 Global POCT Molecular Diagnostics Revenue by Region: 2026-2031
3.4 North America POCT Molecular Diagnostics Market Facts & Figures by Country
3.4.1 North America POCT Molecular Diagnostics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America POCT Molecular Diagnostics Sales by Country (2020-2031)
3.4.3 North America POCT Molecular Diagnostics Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe POCT Molecular Diagnostics Market Facts & Figures by Country
3.5.1 Europe POCT Molecular Diagnostics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe POCT Molecular Diagnostics Sales by Country (2020-2031)
3.5.3 Europe POCT Molecular Diagnostics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific POCT Molecular Diagnostics Market Facts & Figures by Region
3.6.1 Asia Pacific POCT Molecular Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific POCT Molecular Diagnostics Sales by Region (2020-2031)
3.6.3 Asia Pacific POCT Molecular Diagnostics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America POCT Molecular Diagnostics Market Facts & Figures by Country
3.7.1 Latin America POCT Molecular Diagnostics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America POCT Molecular Diagnostics Sales by Country (2020-2031)
3.7.3 Latin America POCT Molecular Diagnostics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa POCT Molecular Diagnostics Market Facts & Figures by Country
3.8.1 Middle East and Africa POCT Molecular Diagnostics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa POCT Molecular Diagnostics Sales by Country (2020-2031)
3.8.3 Middle East and Africa POCT Molecular Diagnostics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global POCT Molecular Diagnostics Sales by Type (2020-2031)
4.1.1 Global POCT Molecular Diagnostics Sales by Type (2020-2025)
4.1.2 Global POCT Molecular Diagnostics Sales by Type (2026-2031)
4.1.3 Global POCT Molecular Diagnostics Sales Market Share by Type (2020-2031)
4.2 Global POCT Molecular Diagnostics Revenue by Type (2020-2031)
4.2.1 Global POCT Molecular Diagnostics Revenue by Type (2020-2025)
4.2.2 Global POCT Molecular Diagnostics Revenue by Type (2026-2031)
4.2.3 Global POCT Molecular Diagnostics Revenue Market Share by Type (2020-2031)
4.3 Global POCT Molecular Diagnostics Price by Type (2020-2031)
5 Segment by Application
5.1 Global POCT Molecular Diagnostics Sales by Application (2020-2031)
5.1.1 Global POCT Molecular Diagnostics Sales by Application (2020-2025)
5.1.2 Global POCT Molecular Diagnostics Sales by Application (2026-2031)
5.1.3 Global POCT Molecular Diagnostics Sales Market Share by Application (2020-2031)
5.2 Global POCT Molecular Diagnostics Revenue by Application (2020-2031)
5.2.1 Global POCT Molecular Diagnostics Revenue by Application (2020-2025)
5.2.2 Global POCT Molecular Diagnostics Revenue by Application (2026-2031)
5.2.3 Global POCT Molecular Diagnostics Revenue Market Share by Application (2020-2031)
5.3 Global POCT Molecular Diagnostics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Ustar Biotechnologies (Hangzhou) Ltd.
6.1.1 Ustar Biotechnologies (Hangzhou) Ltd. Company Information
6.1.2 Ustar Biotechnologies (Hangzhou) Ltd. Description and Business Overview
6.1.3 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product Portfolio
6.1.5 Ustar Biotechnologies (Hangzhou) Ltd. Recent Developments/Updates
6.2 Cepheid
6.2.1 Cepheid Company Information
6.2.2 Cepheid Description and Business Overview
6.2.3 Cepheid POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Cepheid POCT Molecular Diagnostics Product Portfolio
6.2.5 Cepheid Recent Developments/Updates
6.3 Abbott Laboratories
6.3.1 Abbott Laboratories Company Information
6.3.2 Abbott Laboratories Description and Business Overview
6.3.3 Abbott Laboratories POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Abbott Laboratories POCT Molecular Diagnostics Product Portfolio
6.3.5 Abbott Laboratories Recent Developments/Updates
6.4 Roche Holding AG
6.4.1 Roche Holding AG Company Information
6.4.2 Roche Holding AG Description and Business Overview
6.4.3 Roche Holding AG POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Roche Holding AG POCT Molecular Diagnostics Product Portfolio
6.4.5 Roche Holding AG Recent Developments/Updates
6.5 BioFire Diagnostics
6.5.1 BioFire Diagnostics Company Information
6.5.2 BioFire Diagnostics Description and Business Overview
6.5.3 BioFire Diagnostics POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BioFire Diagnostics POCT Molecular Diagnostics Product Portfolio
6.5.5 BioFire Diagnostics Recent Developments/Updates
6.6 Beijing Bohui Innovat Biotech Grp Co Ltd.
6.6.1 Beijing Bohui Innovat Biotech Grp Co Ltd. Company Information
6.6.2 Beijing Bohui Innovat Biotech Grp Co Ltd. Description and Business Overview
6.6.3 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product Portfolio
6.6.5 Beijing Bohui Innovat Biotech Grp Co Ltd. Recent Developments/Updates
6.7 CapitalBio Corporation
6.7.1 CapitalBio Corporation Company Information
6.7.2 CapitalBio Corporation Description and Business Overview
6.7.3 CapitalBio Corporation POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 CapitalBio Corporation POCT Molecular Diagnostics Product Portfolio
6.7.5 CapitalBio Corporation Recent Developments/Updates
6.8 Daan Gene
6.8.1 Daan Gene Company Information
6.8.2 Daan Gene Description and Business Overview
6.8.3 Daan Gene POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Daan Gene POCT Molecular Diagnostics Product Portfolio
6.8.5 Daan Gene Recent Developments/Updates
6.9 Sansure Biotech
6.9.1 Sansure Biotech Company Information
6.9.2 Sansure Biotech Description and Business Overview
6.9.3 Sansure Biotech POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sansure Biotech POCT Molecular Diagnostics Product Portfolio
6.9.5 Sansure Biotech Recent Developments/Updates
6.10 Coyote Bioscience Co., Ltd.
6.10.1 Coyote Bioscience Co., Ltd. Company Information
6.10.2 Coyote Bioscience Co., Ltd. Description and Business Overview
6.10.3 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product Portfolio
6.10.5 Coyote Bioscience Co., Ltd. Recent Developments/Updates
6.11 Genmark Diagnostics, Inc.
6.11.1 Genmark Diagnostics, Inc. Company Information
6.11.2 Genmark Diagnostics, Inc. Description and Business Overview
6.11.3 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product Portfolio
6.11.5 Genmark Diagnostics, Inc. Recent Developments/Updates
6.12 Mobidiag
6.12.1 Mobidiag Company Information
6.12.2 Mobidiag Description and Business Overview
6.12.3 Mobidiag POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Mobidiag POCT Molecular Diagnostics Product Portfolio
6.12.5 Mobidiag Recent Developments/Updates
6.13 Wondfo
6.13.1 Wondfo Company Information
6.13.2 Wondfo Description and Business Overview
6.13.3 Wondfo POCT Molecular Diagnostics Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Wondfo POCT Molecular Diagnostics Product Portfolio
6.13.5 Wondfo Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 POCT Molecular Diagnostics Industry Chain Analysis
7.2 POCT Molecular Diagnostics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 POCT Molecular Diagnostics Production Mode & Process Analysis
7.4 POCT Molecular Diagnostics Sales and Marketing
7.4.1 POCT Molecular Diagnostics Sales Channels
7.4.2 POCT Molecular Diagnostics Distributors
7.5 POCT Molecular Diagnostics Customer Analysis
8 POCT Molecular Diagnostics Market Dynamics
8.1 POCT Molecular Diagnostics Industry Trends
8.2 POCT Molecular Diagnostics Market Drivers
8.3 POCT Molecular Diagnostics Market Challenges
8.4 POCT Molecular Diagnostics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Abbott Laboratories
Roche Holding AG
BioFire Diagnostics
DAAN Gene
Sansure Biotech
Genmark Diagnostics, Inc.
Mobidiag
Wondfo
Coyote Bioscience Co., Ltd.
Ustar Biotechnologies (Hangzhou) Ltd.
Cepheid Inc
Beijing Bohui Innovat Biotech Grp Co Ltd.
CapitalBio Corporation
List of Tables
 Table 1. Global POCT Molecular Diagnostics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global POCT Molecular Diagnostics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global POCT Molecular Diagnostics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global POCT Molecular Diagnostics Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global POCT Molecular Diagnostics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global POCT Molecular Diagnostics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global POCT Molecular Diagnostics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market POCT Molecular Diagnostics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of POCT Molecular Diagnostics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of POCT Molecular Diagnostics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of POCT Molecular Diagnostics, Product Type & Application
 Table 12. Global Key Manufacturers of POCT Molecular Diagnostics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global POCT Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in POCT Molecular Diagnostics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global POCT Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global POCT Molecular Diagnostics Sales by Region (2020-2025) & (K Units)
 Table 18. Global POCT Molecular Diagnostics Sales Market Share by Region (2020-2025)
 Table 19. Global POCT Molecular Diagnostics Sales by Region (2026-2031) & (K Units)
 Table 20. Global POCT Molecular Diagnostics Sales Market Share by Region (2026-2031)
 Table 21. Global POCT Molecular Diagnostics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global POCT Molecular Diagnostics Revenue Market Share by Region (2020-2025)
 Table 23. Global POCT Molecular Diagnostics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global POCT Molecular Diagnostics Revenue Market Share by Region (2026-2031)
 Table 25. North America POCT Molecular Diagnostics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America POCT Molecular Diagnostics Sales by Country (2020-2025) & (K Units)
 Table 27. North America POCT Molecular Diagnostics Sales by Country (2026-2031) & (K Units)
 Table 28. North America POCT Molecular Diagnostics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America POCT Molecular Diagnostics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe POCT Molecular Diagnostics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe POCT Molecular Diagnostics Sales by Country (2020-2025) & (K Units)
 Table 32. Europe POCT Molecular Diagnostics Sales by Country (2026-2031) & (K Units)
 Table 33. Europe POCT Molecular Diagnostics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe POCT Molecular Diagnostics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific POCT Molecular Diagnostics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific POCT Molecular Diagnostics Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific POCT Molecular Diagnostics Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific POCT Molecular Diagnostics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific POCT Molecular Diagnostics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America POCT Molecular Diagnostics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America POCT Molecular Diagnostics Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America POCT Molecular Diagnostics Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America POCT Molecular Diagnostics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America POCT Molecular Diagnostics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa POCT Molecular Diagnostics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa POCT Molecular Diagnostics Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa POCT Molecular Diagnostics Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa POCT Molecular Diagnostics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa POCT Molecular Diagnostics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global POCT Molecular Diagnostics Sales (K Units) by Type (2020-2025)
 Table 51. Global POCT Molecular Diagnostics Sales (K Units) by Type (2026-2031)
 Table 52. Global POCT Molecular Diagnostics Sales Market Share by Type (2020-2025)
 Table 53. Global POCT Molecular Diagnostics Sales Market Share by Type (2026-2031)
 Table 54. Global POCT Molecular Diagnostics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global POCT Molecular Diagnostics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global POCT Molecular Diagnostics Revenue Market Share by Type (2020-2025)
 Table 57. Global POCT Molecular Diagnostics Revenue Market Share by Type (2026-2031)
 Table 58. Global POCT Molecular Diagnostics Price (US$/Unit) by Type (2020-2025)
 Table 59. Global POCT Molecular Diagnostics Price (US$/Unit) by Type (2026-2031)
 Table 60. Global POCT Molecular Diagnostics Sales (K Units) by Application (2020-2025)
 Table 61. Global POCT Molecular Diagnostics Sales (K Units) by Application (2026-2031)
 Table 62. Global POCT Molecular Diagnostics Sales Market Share by Application (2020-2025)
 Table 63. Global POCT Molecular Diagnostics Sales Market Share by Application (2026-2031)
 Table 64. Global POCT Molecular Diagnostics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global POCT Molecular Diagnostics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global POCT Molecular Diagnostics Revenue Market Share by Application (2020-2025)
 Table 67. Global POCT Molecular Diagnostics Revenue Market Share by Application (2026-2031)
 Table 68. Global POCT Molecular Diagnostics Price (US$/Unit) by Application (2020-2025)
 Table 69. Global POCT Molecular Diagnostics Price (US$/Unit) by Application (2026-2031)
 Table 70. Ustar Biotechnologies (Hangzhou) Ltd. Company Information
 Table 71. Ustar Biotechnologies (Hangzhou) Ltd. Description and Business Overview
 Table 72. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Ustar Biotechnologies (Hangzhou) Ltd. POCT Molecular Diagnostics Product
 Table 74. Ustar Biotechnologies (Hangzhou) Ltd. Recent Developments/Updates
 Table 75. Cepheid Company Information
 Table 76. Cepheid Description and Business Overview
 Table 77. Cepheid POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Cepheid POCT Molecular Diagnostics Product
 Table 79. Cepheid Recent Developments/Updates
 Table 80. Abbott Laboratories Company Information
 Table 81. Abbott Laboratories Description and Business Overview
 Table 82. Abbott Laboratories POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Abbott Laboratories POCT Molecular Diagnostics Product
 Table 84. Abbott Laboratories Recent Developments/Updates
 Table 85. Roche Holding AG Company Information
 Table 86. Roche Holding AG Description and Business Overview
 Table 87. Roche Holding AG POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Roche Holding AG POCT Molecular Diagnostics Product
 Table 89. Roche Holding AG Recent Developments/Updates
 Table 90. BioFire Diagnostics Company Information
 Table 91. BioFire Diagnostics Description and Business Overview
 Table 92. BioFire Diagnostics POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. BioFire Diagnostics POCT Molecular Diagnostics Product
 Table 94. BioFire Diagnostics Recent Developments/Updates
 Table 95. Beijing Bohui Innovat Biotech Grp Co Ltd. Company Information
 Table 96. Beijing Bohui Innovat Biotech Grp Co Ltd. Description and Business Overview
 Table 97. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Beijing Bohui Innovat Biotech Grp Co Ltd. POCT Molecular Diagnostics Product
 Table 99. Beijing Bohui Innovat Biotech Grp Co Ltd. Recent Developments/Updates
 Table 100. CapitalBio Corporation Company Information
 Table 101. CapitalBio Corporation Description and Business Overview
 Table 102. CapitalBio Corporation POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. CapitalBio Corporation POCT Molecular Diagnostics Product
 Table 104. CapitalBio Corporation Recent Developments/Updates
 Table 105. Daan Gene Company Information
 Table 106. Daan Gene Description and Business Overview
 Table 107. Daan Gene POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Daan Gene POCT Molecular Diagnostics Product
 Table 109. Daan Gene Recent Developments/Updates
 Table 110. Sansure Biotech Company Information
 Table 111. Sansure Biotech Description and Business Overview
 Table 112. Sansure Biotech POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Sansure Biotech POCT Molecular Diagnostics Product
 Table 114. Sansure Biotech Recent Developments/Updates
 Table 115. Coyote Bioscience Co., Ltd. Company Information
 Table 116. Coyote Bioscience Co., Ltd. Description and Business Overview
 Table 117. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Coyote Bioscience Co., Ltd. POCT Molecular Diagnostics Product
 Table 119. Coyote Bioscience Co., Ltd. Recent Developments/Updates
 Table 120. Genmark Diagnostics, Inc. Company Information
 Table 121. Genmark Diagnostics, Inc. Description and Business Overview
 Table 122. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Genmark Diagnostics, Inc. POCT Molecular Diagnostics Product
 Table 124. Genmark Diagnostics, Inc. Recent Developments/Updates
 Table 125. Mobidiag Company Information
 Table 126. Mobidiag Description and Business Overview
 Table 127. Mobidiag POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Mobidiag POCT Molecular Diagnostics Product
 Table 129. Mobidiag Recent Developments/Updates
 Table 130. Wondfo Company Information
 Table 131. Wondfo Description and Business Overview
 Table 132. Wondfo POCT Molecular Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Wondfo POCT Molecular Diagnostics Product
 Table 134. Wondfo Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. POCT Molecular Diagnostics Distributors List
 Table 138. POCT Molecular Diagnostics Customers List
 Table 139. POCT Molecular Diagnostics Market Trends
 Table 140. POCT Molecular Diagnostics Market Drivers
 Table 141. POCT Molecular Diagnostics Market Challenges
 Table 142. POCT Molecular Diagnostics Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of POCT Molecular Diagnostics
 Figure 2. Global POCT Molecular Diagnostics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global POCT Molecular Diagnostics Market Share by Type: 2024 & 2031
 Figure 4. Molecular Point-of-Care Diagnostics Product Picture
 Figure 5. Near-Patient Molecular Product Picture
 Figure 6. Global POCT Molecular Diagnostics Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global POCT Molecular Diagnostics Market Share by Application: 2024 & 2031
 Figure 8. Microbiology Laboratory
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Global POCT Molecular Diagnostics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global POCT Molecular Diagnostics Market Size (2020-2031) & (US$ Million)
 Figure 13. Global POCT Molecular Diagnostics Sales (2020-2031) & (K Units)
 Figure 14. Global POCT Molecular Diagnostics Average Price (US$/Unit) & (2020-2031)
 Figure 15. POCT Molecular Diagnostics Report Years Considered
 Figure 16. POCT Molecular Diagnostics Sales Share by Manufacturers in 2024
 Figure 17. Global POCT Molecular Diagnostics Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest POCT Molecular Diagnostics Players: Market Share by Revenue in POCT Molecular Diagnostics in 2024
 Figure 19. POCT Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global POCT Molecular Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America POCT Molecular Diagnostics Sales Market Share by Country (2020-2031)
 Figure 22. North America POCT Molecular Diagnostics Revenue Market Share by Country (2020-2031)
 Figure 23. United States POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe POCT Molecular Diagnostics Sales Market Share by Country (2020-2031)
 Figure 26. Europe POCT Molecular Diagnostics Revenue Market Share by Country (2020-2031)
 Figure 27. Germany POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific POCT Molecular Diagnostics Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific POCT Molecular Diagnostics Revenue Market Share by Region (2020-2031)
 Figure 34. China POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America POCT Molecular Diagnostics Sales Market Share by Country (2020-2031)
 Figure 42. Latin America POCT Molecular Diagnostics Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa POCT Molecular Diagnostics Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa POCT Molecular Diagnostics Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE POCT Molecular Diagnostics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of POCT Molecular Diagnostics by Type (2020-2031)
 Figure 52. Global Revenue Market Share of POCT Molecular Diagnostics by Type (2020-2031)
 Figure 53. Global POCT Molecular Diagnostics Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of POCT Molecular Diagnostics by Application (2020-2031)
 Figure 55. Global Revenue Market Share of POCT Molecular Diagnostics by Application (2020-2031)
 Figure 56. Global POCT Molecular Diagnostics Price (US$/Unit) by Application (2020-2031)
 Figure 57. POCT Molecular Diagnostics Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global POCT Molecular Diagnostics Technology Market Research Report 2025
Global Point of Care Molecular Diagnostics Technology Market Research Report 2024
Global Molecular Diagnostics in Point of Care Market Research Report 2024
Molecular Diagnostic Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Veterinary Point Of Care Diagnostics Market Research Report 2025
Point of care Testing POCT for Cardiovascular Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Diagnostic Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Point of care Testing POCT for Chronic Disease Market Research Report 2024
Global Point of care Testing POCT for Infectious Diseases Market Research Report 2024
Global Point of care Molecular Diagnostic Solution Market Research Report 2025
Point of Care and Rapid Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Diagnostic Platform Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Molecular Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Molecular Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Molecular Diagnosis and Therapy Market Insights Forecast to 2030
Global Oncology Based Molecular Diagnostics Market Insights Forecast to 2030
Global Point of care Testing POCT for Inflammatory Market Research Report 2024
POCT Rapid Diagnostic Reagent Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Primary Care POC Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global POCT Diagnostic Device Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions